Anti-trust lawsuit against Natco Pharma over generic cancer drug dismissed in US

Natco Pharma on December 21  said anti-trust claims against it regarding a generic cancer treatment drug in the US have been dismissed. In September this year, the company had stated that along with Celgene Corporation, Bristol Myers Squibb, Breckenridge Pharmaceutical Inc and others, it had been named defendants by Louisiana Health Service & Indemnity Company, D/B/A Blue Cross and Blue Shield of Losisiana and HMO Louisiana Inc, regarding anti-cancer treatment medication Pomalidomide.

“The plaintiffs voluntarily dismissed Breckenridge Pharmaceutical Inc and Natco Pharma Ltd from the case. All claims against the company in the litigation have now been dismissed,” Natco Pharma said in a regulatory filing. Breckenridge is the ANDA (Abbreviated New Drug Application) holder and front-end marketing partner for the Pomalidomide capsules generic product in the US, it added.

Natco’s Pomalidomide capsules generic product has not yet launched in the US, the company said.

Related Posts

4 arrested in blood plasma adulteration racket

Vehicles carrying plasma were diverted before reaching pharmaceutical companies to a location in Moriya near Ahmedabad Ahmedabad rural police on Monday arrested four persons from Ahmedabad and Mumbai, including a…

159 drug samples fail CDSCO quality test in May, 1 flagged spurious

The latest list features several common medicines such as paracetamol, metformin combos (for diabetes), amoxicillin formulations (antibiotic), vitamin supplements, and cough syrups. New Delhi: During their monthly quality review, the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

4 arrested in blood plasma adulteration racket

4 arrested in blood plasma adulteration racket

159 drug samples fail CDSCO quality test in May, 1 flagged spurious

159 drug samples fail CDSCO quality test in May, 1 flagged spurious

Kerala HC upholds DC’s move against vague discount boards; dismisses chemists’ petitions

Kerala HC upholds DC’s move against vague discount boards; dismisses chemists’ petitions

Stakeholders push for stronger supply chain compliance through GSDP training

Stakeholders push for stronger supply chain compliance through GSDP training

India’s Battle Against Addiction: From Liquor Ban To ‘Dry Drugs’, Bihar’s Youth Trapped In A Growing Narcotics Crisis

India’s Battle Against Addiction: From Liquor Ban To ‘Dry Drugs’, Bihar’s Youth Trapped In A Growing Narcotics Crisis

Ovarian Reserve is ‘Jumping Age’ in Indian Women, SHE Delhi red flags

Ovarian Reserve is ‘Jumping Age’ in Indian Women, SHE Delhi red flags